IDH1/2 mutations are seen in patients with cytogenetically normal AML, MDS, MPN, angioimmunoblastic T-cell lymphoma, glioma, cholangiocarcinoma, and chondrosarcoma [27,35]. The gene discussed is IDH1; the disease is central nervous system cancer.